pipette
ESEspañol

Ascorbate is a physiological tumor suppressor metabolite in leukemia

T. Wijshake, J. Rose, J. H. Jun, E. O. Kwarteng, X. Yang, J. Zielke, S. Mahesula, L. Li, S. S. Chung, S. Comazzetto, S. J. Morrison, W. Chen, M. Agathocleous

PreprintClaims a big stepReal-world use

In the authors' words

Accumulation of oncometabolites promotes tumorigenesis, but it is not known if there are naturally occurring tumor suppressor metabolites whose deficiency within cancer-initiating cells causes cancer. Many leukemia patients are ascorbate deficient. Here we show that hematopoietic-specific ascorbate depletion in mice is sufficient to cause or promote leukemogenesis. Hematopoietic-specific ascorbate depletion promoted leukemogenesis by acting within leukemia initiating cells. Ascorbate depletion in myeloid leukemia expanded plasmacytoid dendritic cells, an effect mediated by the ascorbate molecular targets TET2 and TET3. Leukemia cells accumulated ascorbate as part of a tumor suppressor response to neoplastic proliferation that limited progression but depleted circulating ascorbate. Ascorbate restoration in mice with established leukemias extended survival. Hematopoietic-specific ascorbate depletion caused leukemia in collaboration with TET2 loss and was sufficient to cause leukemia with high penetrance even in the absence of other engineered mutations. These results identify ascorbate as a physiological tumor suppressor metabolite in blood cancers.

Main resultThe abstract does not state a limitation.

In plain words AI summary

The researchers depleted ascorbate only in blood-forming cells in mice. This depletion was enough to cause or promote leukemia development. Giving ascorbate back to mice with existing leukemia extended their survival. The authors conclude that ascorbate acts as a natural tumor suppressor in blood cancers.

Written by Kimi K2.5 using only the abstract above. Jev checked that every sentence is supported by the abstract sentences it cites, and removed any that were not. Point at a sentence to highlight its source. 1 sentence was removed for not being supported by the abstract.

Appeared: Thursday, October 22. bioRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.10.20.760526